Stada Study Debunks German Sleep Aid Reverse-Switch Worries
Executive Summary
Ahead of an incoming German reverse-switch ruling, Stada publishes reslts of a study showing no evidence of increased risk of falling in connection with the use of antihistamine-based sleeping pills such as the company’s Hoggar Night brand.
You may also be interested in...
Stada Blasts German Sleep Aid Reverse Switch
Stada criticizes German switch committee's recommendation to restrict access to first generation antihistamines with a sedative effect for over-65s.
German Switch Committee Meets: Sumatriptan Goes Again, Antihistamine Reverse-Switch Rejected, For Now
Germany’s Expert Committee for Prescription recommends prescription-to-OTC reclassifications of sumatriptan for migraines and liquid ibuprofen, but rejects an OTC switch for ketoprofen and the reverse-switch of sedative antihistamines for over 65s.
German Sleep Expert Urges Committee Not To Reverse-Switch Antihistamines
Chair of the German Sleep Society, Ingo Fietze, calls on members of Germany's Expert Committee for Prescription to vote down the proposal to reverse-switch first-generation antihistamines with sedative effect for patients over the age of 65.